Chilton Investment Company’s Novo Nordisk NVO Stock Holding History

Chilton Investment Company’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25,397	Closed	-$1.29M	–	313
2025 Q4	$1.29M	Buy	+25,397	New	+$1.3M	0.03%	136
2025 Q3	–	Sell	-11,460	Closed	-$791K	–	284
2025 Q2	$791K	Buy	11,460 +8,349	+268%	+$568K	0.02%	121
2025 Q1	$216K	Sell	3,111 -25,914	-89%	-$2.14M	0.01%	199
2024 Q4	$2.5M	Buy	29,025 +24,198	+501%	+$2.62M	0.06%	86
2024 Q3	$575K	Sell	4,827 -5,213	-52%	-$695K	0.02%	134
2024 Q2	$1.43M	Buy	10,040 +5,381	+115%	+$713K	0.04%	97
2024 Q1	$598K	Sell	4,659 -104	-2%	-$12.4K	0.02%	129
2023 Q4	$493K	Sell	4,763 -30,977	-87%	-$3.06M	0.01%	124
2023 Q3	$3.25M	Buy	+35,740	New	+$3.15M	0.1%	63

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Chilton Investment Company's NVO Position: Q1 2026 in Review

Chilton Investment Company sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 25,397 shares — an estimated $1.29M sold.

Chilton Investment Company first reported a position in NVO in Q3 2023 and held it in 9 quarters. The position peaked at $3.25M in Q3 2023. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Chilton Investment Company reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
Chilton Investment Company sold 25,397 Novo Nordisk shares in Q1 2026, an estimated $1.29M.
Chilton Investment Company first reported a position in Novo Nordisk in Q3 2023 and held it in 9 quarters.
Chilton Investment Company's Novo Nordisk position peaked at $3.25M in Q3 2023.
1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Chilton Investment Company's 13F filing for Q1 2026, filed 15 May 2026.